Help us improve outcomes for all ROS1+ cancers

The ROS1ders is a nonprofit corporation with a membership of patients, caregivers, and family members living with ROS1+ cancers in over 30 countries. Our mission is to improve outcomes for all ROS1+ cancers through community, education, and research. Our members are primarily engaged patients who join us to save their own lives.

We are raising money to support patient-partnered research into our own disease. ROS1-positive (ROS1+) cancer is relatively rare. We need to generate more research to move towards a cure, and we could use your help.

Our Scientific Advisory Board helps us identify new projects that might have the most impact on ROS1+ cancer. Our ROS1+ Cancer Innovation Award seed grant program has disbursed hundreds of thousands of dollars to projects critical to improving patient outcomes. A new program aims to collect patient specimens and real-world data, generate new models of our cancer, and share these resources with researchers.

In addition to research, The ROS1ders focus on community and education. We maintain a robust website that’s become a go-to resource for both patients and health care professionals, and administer an active private support group online. We also host the in-person ROS1ders PRIME Summit (PRIME = Patient and Researcher Interaction for Mutual Education). The Summit is one of the most meaningful ways our community comes together. It offers a rare opportunity for ROS1+ patients and their supporters to be in the same room with others who truly understand the questions, decisions, uncertainty, and hope that come with this diagnosis.

With your help, we will continue moving forward and improving outcomes for people living with ROS1+ cancer. Every amount makes a difference.

Thanks for supporting The ROS1ders!